Last reviewed · How we verify
infections that are proven or strongly suspected to be caused by susceptible bacteria
Approved treatments
- Xerava · Tetraphase Pharms
Xerava works by inhibiting protein synthesis in bacteria, ultimately leading to their death.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- infections that are proven or strongly suspected to be caused by susceptible bacteria patent landscape — cliff calendar, originator estates, attackable patents
- infections that are proven or strongly suspected to be caused by susceptible bacteria treatment landscape brief
- infections that are proven or strongly suspected to be caused by susceptible bacteria treatment updates RSS
Frequently asked questions about infections that are proven or strongly suspected to be caused by susceptible bacteria
What drugs treat infections that are proven or strongly suspected to be caused by susceptible bacteria?
Tracked treatments include Xerava.
What is the treatment for infections that are proven or strongly suspected to be caused by susceptible bacteria?
Standard treatment for infections that are proven or strongly suspected to be caused by susceptible bacteria includes Xerava. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: infections that are proven or strongly suspected to be caused by susceptible bacteria patent cliff · infections that are proven or strongly suspected to be caused by susceptible bacteria CI report
- Treatment: Xerava · Tetraphase Pharms
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing